Interaction of Inhibitors of the Vacuolar H+-ATPase with the Transmembrane Vo-Sector

The macrolide antibiotic concanamycin A and a designed derivative of 5-(2-indolyl)-2,4-pentadienamide (INDOL0) are potent inhibitors of vacuolar H+-ATPases, with IC50 values in the low and medium nanomolar range, respectively. Interaction of these V-ATPase inhibitors with spin-labeled subunit c in t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 2004-09, Vol.43 (38), p.12297-12305
Hauptverfasser: Páli, Tibor, Whyteside, Graham, Dixon, Neil, Kee, Terence P, Ball, Stephen, Harrison, Michael A, Findlay, John B. C, Finbow, Malcolm E, Marsh, Derek
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12305
container_issue 38
container_start_page 12297
container_title Biochemistry (Easton)
container_volume 43
creator Páli, Tibor
Whyteside, Graham
Dixon, Neil
Kee, Terence P
Ball, Stephen
Harrison, Michael A
Findlay, John B. C
Finbow, Malcolm E
Marsh, Derek
description The macrolide antibiotic concanamycin A and a designed derivative of 5-(2-indolyl)-2,4-pentadienamide (INDOL0) are potent inhibitors of vacuolar H+-ATPases, with IC50 values in the low and medium nanomolar range, respectively. Interaction of these V-ATPase inhibitors with spin-labeled subunit c in the transmembrane Vo-sector of the ATPase was studied by using the transport-active 16-kDa proteolipid analogue of subunit c from the hepatopancreas of Nephrops norvegicus. Analogous experiments were also performed with vacuolar membranes from Saccharomyces cerevisiae. Membranous preparations of the Nephrops 16-kDa proteolipid were spin-labeled either on the unique cysteine C54, with a nitroxyl maleimide, or on the functionally essential glutamate E140, with a nitroxyl analogue of dicyclohexylcarbodiimide (DCCD). These residues were previously demonstrated to be accessible to lipid. Interaction of the inhibitors with these lipid-exposed residues was studied by using both conventional and saturation transfer EPR spectroscopy. Immobilization of the spin-labeled residues by the inhibitors was observed on both the nanosecond and microsecond time scales. The perturbation by INDOL0 was mostly greater than that by concanamycin A. Qualitatively similar but quantitatively greater effects were obtained with the same spin-label reagents and vacuolar membranes in which the Nephrops 16-kDa proteolipid was expressed in place of the native vma3p proteolipid of yeast. The spin-label immobilization corresponds to a direct interaction of the inhibitors with these intramembranous sites on the protein. A mutational analysis on transmembrane segment 4 known to give resistance to concanamycin A also gave partial resistance to INDOL0. The results are consistent with transmembrane segments 2 and 4 of the 16-kDa putative four-helix bundle, and particularly the functionally essential protonation locus, being involved in the inhibitor binding sites. Inhibition of proton transport may also involve immobilization of the overall rotation of the proteolipid subunit assembly.
doi_str_mv 10.1021/bi0493867
format Article
fullrecord <record><control><sourceid>acs_pubme</sourceid><recordid>TN_cdi_pubmed_primary_15379568</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>h34822382</sourcerecordid><originalsourceid>FETCH-LOGICAL-a190t-12db67b6bff704d8aa5ac8e13270f069fbc5c33c988bb97f7e5a462e78b1396f3</originalsourceid><addsrcrecordid>eNo9kFFLwzAUhYMobk4f_APSF58kmjRN0jyO6txk4GBVxJeQZAnrXNuRZKj_3s7png6H893LvQeAS4xuMUrxna5QJkjO-BHoY5oimAlBj0EfIcRgKhjqgbMQVp3NEM9OQQ9TwgVleR-UkyZar0ys2iZpXTJplpWuYuvDzsWlTV6V2bZr5ZPxDRyWMxVs8lnF5W9WetWE2ta6045s4dyabvYcnDi1DvbiTwfgZfRQFmM4fX6cFMMpVFigCHG60Ixrpp3jKFvkSlFlcotJypFDTDhtqCHEiDzXWnDHLVUZSy3PNSaCOTIAV_u9m62u7UJufFUr_y3_3-sAuAeqEO3XIVf-QzJOOJXlbC6L0f0TLtCbfO_46z2vTJCrduub7nyJkdzVLA81kx8vpWth</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interaction of Inhibitors of the Vacuolar H+-ATPase with the Transmembrane Vo-Sector</title><source>ACS Publications</source><source>MEDLINE</source><creator>Páli, Tibor ; Whyteside, Graham ; Dixon, Neil ; Kee, Terence P ; Ball, Stephen ; Harrison, Michael A ; Findlay, John B. C ; Finbow, Malcolm E ; Marsh, Derek</creator><creatorcontrib>Páli, Tibor ; Whyteside, Graham ; Dixon, Neil ; Kee, Terence P ; Ball, Stephen ; Harrison, Michael A ; Findlay, John B. C ; Finbow, Malcolm E ; Marsh, Derek</creatorcontrib><description>The macrolide antibiotic concanamycin A and a designed derivative of 5-(2-indolyl)-2,4-pentadienamide (INDOL0) are potent inhibitors of vacuolar H+-ATPases, with IC50 values in the low and medium nanomolar range, respectively. Interaction of these V-ATPase inhibitors with spin-labeled subunit c in the transmembrane Vo-sector of the ATPase was studied by using the transport-active 16-kDa proteolipid analogue of subunit c from the hepatopancreas of Nephrops norvegicus. Analogous experiments were also performed with vacuolar membranes from Saccharomyces cerevisiae. Membranous preparations of the Nephrops 16-kDa proteolipid were spin-labeled either on the unique cysteine C54, with a nitroxyl maleimide, or on the functionally essential glutamate E140, with a nitroxyl analogue of dicyclohexylcarbodiimide (DCCD). These residues were previously demonstrated to be accessible to lipid. Interaction of the inhibitors with these lipid-exposed residues was studied by using both conventional and saturation transfer EPR spectroscopy. Immobilization of the spin-labeled residues by the inhibitors was observed on both the nanosecond and microsecond time scales. The perturbation by INDOL0 was mostly greater than that by concanamycin A. Qualitatively similar but quantitatively greater effects were obtained with the same spin-label reagents and vacuolar membranes in which the Nephrops 16-kDa proteolipid was expressed in place of the native vma3p proteolipid of yeast. The spin-label immobilization corresponds to a direct interaction of the inhibitors with these intramembranous sites on the protein. A mutational analysis on transmembrane segment 4 known to give resistance to concanamycin A also gave partial resistance to INDOL0. The results are consistent with transmembrane segments 2 and 4 of the 16-kDa putative four-helix bundle, and particularly the functionally essential protonation locus, being involved in the inhibitor binding sites. Inhibition of proton transport may also involve immobilization of the overall rotation of the proteolipid subunit assembly.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi0493867</identifier><identifier>PMID: 15379568</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Binding Sites ; Dicyclohexylcarbodiimide - analogs &amp; derivatives ; Dicyclohexylcarbodiimide - metabolism ; Dicyclohexylcarbodiimide - pharmacology ; Electron Spin Resonance Spectroscopy ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - metabolism ; Enzyme Inhibitors - pharmacology ; Inhibitory Concentration 50 ; Intracellular Membranes - metabolism ; Macrolides - metabolism ; Macrolides - pharmacology ; Molecular Structure ; Nephropidae - cytology ; Nephropidae - enzymology ; Proteolipids - chemistry ; Proteolipids - metabolism ; Protons ; Saccharomyces cerevisiae - cytology ; Saccharomyces cerevisiae - enzymology ; Spin Labels ; Temperature ; Vacuolar Proton-Translocating ATPases - antagonists &amp; inhibitors ; Vacuolar Proton-Translocating ATPases - chemistry ; Vacuolar Proton-Translocating ATPases - metabolism ; Vacuoles - enzymology</subject><ispartof>Biochemistry (Easton), 2004-09, Vol.43 (38), p.12297-12305</ispartof><rights>Copyright © 2004 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi0493867$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi0493867$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15379568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Páli, Tibor</creatorcontrib><creatorcontrib>Whyteside, Graham</creatorcontrib><creatorcontrib>Dixon, Neil</creatorcontrib><creatorcontrib>Kee, Terence P</creatorcontrib><creatorcontrib>Ball, Stephen</creatorcontrib><creatorcontrib>Harrison, Michael A</creatorcontrib><creatorcontrib>Findlay, John B. C</creatorcontrib><creatorcontrib>Finbow, Malcolm E</creatorcontrib><creatorcontrib>Marsh, Derek</creatorcontrib><title>Interaction of Inhibitors of the Vacuolar H+-ATPase with the Transmembrane Vo-Sector</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>The macrolide antibiotic concanamycin A and a designed derivative of 5-(2-indolyl)-2,4-pentadienamide (INDOL0) are potent inhibitors of vacuolar H+-ATPases, with IC50 values in the low and medium nanomolar range, respectively. Interaction of these V-ATPase inhibitors with spin-labeled subunit c in the transmembrane Vo-sector of the ATPase was studied by using the transport-active 16-kDa proteolipid analogue of subunit c from the hepatopancreas of Nephrops norvegicus. Analogous experiments were also performed with vacuolar membranes from Saccharomyces cerevisiae. Membranous preparations of the Nephrops 16-kDa proteolipid were spin-labeled either on the unique cysteine C54, with a nitroxyl maleimide, or on the functionally essential glutamate E140, with a nitroxyl analogue of dicyclohexylcarbodiimide (DCCD). These residues were previously demonstrated to be accessible to lipid. Interaction of the inhibitors with these lipid-exposed residues was studied by using both conventional and saturation transfer EPR spectroscopy. Immobilization of the spin-labeled residues by the inhibitors was observed on both the nanosecond and microsecond time scales. The perturbation by INDOL0 was mostly greater than that by concanamycin A. Qualitatively similar but quantitatively greater effects were obtained with the same spin-label reagents and vacuolar membranes in which the Nephrops 16-kDa proteolipid was expressed in place of the native vma3p proteolipid of yeast. The spin-label immobilization corresponds to a direct interaction of the inhibitors with these intramembranous sites on the protein. A mutational analysis on transmembrane segment 4 known to give resistance to concanamycin A also gave partial resistance to INDOL0. The results are consistent with transmembrane segments 2 and 4 of the 16-kDa putative four-helix bundle, and particularly the functionally essential protonation locus, being involved in the inhibitor binding sites. Inhibition of proton transport may also involve immobilization of the overall rotation of the proteolipid subunit assembly.</description><subject>Animals</subject><subject>Binding Sites</subject><subject>Dicyclohexylcarbodiimide - analogs &amp; derivatives</subject><subject>Dicyclohexylcarbodiimide - metabolism</subject><subject>Dicyclohexylcarbodiimide - pharmacology</subject><subject>Electron Spin Resonance Spectroscopy</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Inhibitory Concentration 50</subject><subject>Intracellular Membranes - metabolism</subject><subject>Macrolides - metabolism</subject><subject>Macrolides - pharmacology</subject><subject>Molecular Structure</subject><subject>Nephropidae - cytology</subject><subject>Nephropidae - enzymology</subject><subject>Proteolipids - chemistry</subject><subject>Proteolipids - metabolism</subject><subject>Protons</subject><subject>Saccharomyces cerevisiae - cytology</subject><subject>Saccharomyces cerevisiae - enzymology</subject><subject>Spin Labels</subject><subject>Temperature</subject><subject>Vacuolar Proton-Translocating ATPases - antagonists &amp; inhibitors</subject><subject>Vacuolar Proton-Translocating ATPases - chemistry</subject><subject>Vacuolar Proton-Translocating ATPases - metabolism</subject><subject>Vacuoles - enzymology</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kFFLwzAUhYMobk4f_APSF58kmjRN0jyO6txk4GBVxJeQZAnrXNuRZKj_3s7png6H893LvQeAS4xuMUrxna5QJkjO-BHoY5oimAlBj0EfIcRgKhjqgbMQVp3NEM9OQQ9TwgVleR-UkyZar0ys2iZpXTJplpWuYuvDzsWlTV6V2bZr5ZPxDRyWMxVs8lnF5W9WetWE2ta6045s4dyabvYcnDi1DvbiTwfgZfRQFmM4fX6cFMMpVFigCHG60Ixrpp3jKFvkSlFlcotJypFDTDhtqCHEiDzXWnDHLVUZSy3PNSaCOTIAV_u9m62u7UJufFUr_y3_3-sAuAeqEO3XIVf-QzJOOJXlbC6L0f0TLtCbfO_46z2vTJCrduub7nyJkdzVLA81kx8vpWth</recordid><startdate>20040928</startdate><enddate>20040928</enddate><creator>Páli, Tibor</creator><creator>Whyteside, Graham</creator><creator>Dixon, Neil</creator><creator>Kee, Terence P</creator><creator>Ball, Stephen</creator><creator>Harrison, Michael A</creator><creator>Findlay, John B. C</creator><creator>Finbow, Malcolm E</creator><creator>Marsh, Derek</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20040928</creationdate><title>Interaction of Inhibitors of the Vacuolar H+-ATPase with the Transmembrane Vo-Sector</title><author>Páli, Tibor ; Whyteside, Graham ; Dixon, Neil ; Kee, Terence P ; Ball, Stephen ; Harrison, Michael A ; Findlay, John B. C ; Finbow, Malcolm E ; Marsh, Derek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a190t-12db67b6bff704d8aa5ac8e13270f069fbc5c33c988bb97f7e5a462e78b1396f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Binding Sites</topic><topic>Dicyclohexylcarbodiimide - analogs &amp; derivatives</topic><topic>Dicyclohexylcarbodiimide - metabolism</topic><topic>Dicyclohexylcarbodiimide - pharmacology</topic><topic>Electron Spin Resonance Spectroscopy</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Inhibitory Concentration 50</topic><topic>Intracellular Membranes - metabolism</topic><topic>Macrolides - metabolism</topic><topic>Macrolides - pharmacology</topic><topic>Molecular Structure</topic><topic>Nephropidae - cytology</topic><topic>Nephropidae - enzymology</topic><topic>Proteolipids - chemistry</topic><topic>Proteolipids - metabolism</topic><topic>Protons</topic><topic>Saccharomyces cerevisiae - cytology</topic><topic>Saccharomyces cerevisiae - enzymology</topic><topic>Spin Labels</topic><topic>Temperature</topic><topic>Vacuolar Proton-Translocating ATPases - antagonists &amp; inhibitors</topic><topic>Vacuolar Proton-Translocating ATPases - chemistry</topic><topic>Vacuolar Proton-Translocating ATPases - metabolism</topic><topic>Vacuoles - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Páli, Tibor</creatorcontrib><creatorcontrib>Whyteside, Graham</creatorcontrib><creatorcontrib>Dixon, Neil</creatorcontrib><creatorcontrib>Kee, Terence P</creatorcontrib><creatorcontrib>Ball, Stephen</creatorcontrib><creatorcontrib>Harrison, Michael A</creatorcontrib><creatorcontrib>Findlay, John B. C</creatorcontrib><creatorcontrib>Finbow, Malcolm E</creatorcontrib><creatorcontrib>Marsh, Derek</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Páli, Tibor</au><au>Whyteside, Graham</au><au>Dixon, Neil</au><au>Kee, Terence P</au><au>Ball, Stephen</au><au>Harrison, Michael A</au><au>Findlay, John B. C</au><au>Finbow, Malcolm E</au><au>Marsh, Derek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction of Inhibitors of the Vacuolar H+-ATPase with the Transmembrane Vo-Sector</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2004-09-28</date><risdate>2004</risdate><volume>43</volume><issue>38</issue><spage>12297</spage><epage>12305</epage><pages>12297-12305</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>The macrolide antibiotic concanamycin A and a designed derivative of 5-(2-indolyl)-2,4-pentadienamide (INDOL0) are potent inhibitors of vacuolar H+-ATPases, with IC50 values in the low and medium nanomolar range, respectively. Interaction of these V-ATPase inhibitors with spin-labeled subunit c in the transmembrane Vo-sector of the ATPase was studied by using the transport-active 16-kDa proteolipid analogue of subunit c from the hepatopancreas of Nephrops norvegicus. Analogous experiments were also performed with vacuolar membranes from Saccharomyces cerevisiae. Membranous preparations of the Nephrops 16-kDa proteolipid were spin-labeled either on the unique cysteine C54, with a nitroxyl maleimide, or on the functionally essential glutamate E140, with a nitroxyl analogue of dicyclohexylcarbodiimide (DCCD). These residues were previously demonstrated to be accessible to lipid. Interaction of the inhibitors with these lipid-exposed residues was studied by using both conventional and saturation transfer EPR spectroscopy. Immobilization of the spin-labeled residues by the inhibitors was observed on both the nanosecond and microsecond time scales. The perturbation by INDOL0 was mostly greater than that by concanamycin A. Qualitatively similar but quantitatively greater effects were obtained with the same spin-label reagents and vacuolar membranes in which the Nephrops 16-kDa proteolipid was expressed in place of the native vma3p proteolipid of yeast. The spin-label immobilization corresponds to a direct interaction of the inhibitors with these intramembranous sites on the protein. A mutational analysis on transmembrane segment 4 known to give resistance to concanamycin A also gave partial resistance to INDOL0. The results are consistent with transmembrane segments 2 and 4 of the 16-kDa putative four-helix bundle, and particularly the functionally essential protonation locus, being involved in the inhibitor binding sites. Inhibition of proton transport may also involve immobilization of the overall rotation of the proteolipid subunit assembly.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>15379568</pmid><doi>10.1021/bi0493867</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 2004-09, Vol.43 (38), p.12297-12305
issn 0006-2960
1520-4995
language eng
recordid cdi_pubmed_primary_15379568
source ACS Publications; MEDLINE
subjects Animals
Binding Sites
Dicyclohexylcarbodiimide - analogs & derivatives
Dicyclohexylcarbodiimide - metabolism
Dicyclohexylcarbodiimide - pharmacology
Electron Spin Resonance Spectroscopy
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - metabolism
Enzyme Inhibitors - pharmacology
Inhibitory Concentration 50
Intracellular Membranes - metabolism
Macrolides - metabolism
Macrolides - pharmacology
Molecular Structure
Nephropidae - cytology
Nephropidae - enzymology
Proteolipids - chemistry
Proteolipids - metabolism
Protons
Saccharomyces cerevisiae - cytology
Saccharomyces cerevisiae - enzymology
Spin Labels
Temperature
Vacuolar Proton-Translocating ATPases - antagonists & inhibitors
Vacuolar Proton-Translocating ATPases - chemistry
Vacuolar Proton-Translocating ATPases - metabolism
Vacuoles - enzymology
title Interaction of Inhibitors of the Vacuolar H+-ATPase with the Transmembrane Vo-Sector
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T03%3A46%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20of%20Inhibitors%20of%20the%20Vacuolar%20H+-ATPase%20with%20the%20Transmembrane%20Vo-Sector&rft.jtitle=Biochemistry%20(Easton)&rft.au=P%C3%A1li,%20Tibor&rft.date=2004-09-28&rft.volume=43&rft.issue=38&rft.spage=12297&rft.epage=12305&rft.pages=12297-12305&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi0493867&rft_dat=%3Cacs_pubme%3Eh34822382%3C/acs_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15379568&rfr_iscdi=true